First Time Loading...

Immatics NV
NASDAQ:IMTX

Watchlist Manager
Immatics NV Logo
Immatics NV
NASDAQ:IMTX
Watchlist
Price: 10.81 USD 8.86% Market Closed
Updated: May 2, 2024

Immatics NV
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immatics NV
Revenue Peer Comparison

Comparables:
BNTX
MOR
CVAC
BIO
FYB

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Immatics NV
NASDAQ:IMTX
Revenue
€54m
CAGR 3-Years
20%
CAGR 5-Years
70%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Revenue
€3.8B
CAGR 3-Years
99%
CAGR 5-Years
97%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Revenue
€238.3m
CAGR 3-Years
-10%
CAGR 5-Years
26%
CAGR 10-Years
12%
CureVac NV
NASDAQ:CVAC
Revenue
€53.8m
CAGR 3-Years
3%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Revenue
€684.6m
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
3%
Formycon AG
XETRA:FYB
Revenue
€42.5m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
N/A

See Also

What is Immatics NV's Revenue?
Revenue
54m EUR

Based on the financial report for Dec 31, 2023, Immatics NV's Revenue amounts to 54m EUR.

What is Immatics NV's Revenue growth rate?
Revenue CAGR 5Y
70%

Over the last year, the Revenue growth was -69%. The average annual Revenue growth rates for Immatics NV have been 20% over the past three years , 70% over the past five years .